Passive administration of monoclonal antibodies to Anthrolysin O prolong survival in mice lethally infected with Bacillus anthracis

BMC Microbiology

Volumn 8, Issue , 2008, Pages

  Nakouzi, Antonio ^a   Rivera, Johanna ^a   Rest, Richard F ^b   Casadevall, Arturo ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN M; ANTHRAX VACCINE; ANTHROLYSIN O, BACILLUS ANTHRACIS; BACTERIAL PROTEIN; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACILLUS ANTHRACIS; BACTERIAL INFECTION; CONTROLLED STUDY; HYBRIDOMA; IMMUNOGENICITY; MOUSE; NONHUMAN; SURVIVAL RATE; ANIMAL; ANTHRAX; BAGG ALBINO MOUSE; BLOOD; CELL LINE; FEMALE; GENETICS; IMMUNOLOGY; MICROBIOLOGY; PASSIVE IMMUNIZATION; PATHOGENICITY; SURVIVAL;

BACILLUS ANTHRACIS; MUS;

ANIMALS; ANTHRAX; ANTHRAX VACCINES; ANTIBODIES, MONOCLONAL; BACILLUS ANTHRACIS; BACTERIAL PROTEINS; CELL LINE; FEMALE; IMMUNIZATION, PASSIVE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; RECOMBINANT PROTEINS; SURVIVAL ANALYSIS;

EID: 53249145378     PISSN: 14712180     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-8-159     Document Type: Article

References (15)

1. Characterization of anthrolysin O, the Bacillus anthracis cholesterol-dependent cytolysin. JG Shannon CL Ross TM Koehler RF Rest, Infect Immun 2003 71 3183 3189 12761097 10.1128/IAI.71.6.3183-3189.2003
2. Anthrolysin O and other gram-positive cytolysins are toll-like receptor 4 agonists. JM Park VH Ng S Maeda RF Rest M Karin, J Exp Med 2004 200 1647 1655 15611291 10.1084/jem.20041215
3. The Bacillus anthracis cholesterol-dependent cytolysin, Anthrolysin O, kills human neutrophils, monocytes and macrophages. EM Mosser RF Rest, BMC Microbiol 2006 6 56 16790055 10.1186/1471-2180-6-56
4. Bacillus anthracis anthrolysin O and three phospholipases C are functionally redundant in a murine model of inhalation anthrax. BJ Heffernan B Thomason A Herring-Palmer P Hanna, FEMS Microbiol Lett 2007 271 98 105 10.1111/j.1574-6968.2007.00713.x 17419764
5. Immunisation with anthrolysin O or a genetic toxoid protects against challenge with the toxin but not against Bacillus anthracis. GJ Cowan HS Atkins LK Johnson RW Titball TJ Mitchell, Vaccine 2007 25 7197 7205 10.1016/j.vaccine.2007.07.040 17765365
6. Production of monoclonal antibodies: strategy and tactics. SF de St Groth D Scheidegger, J Immunol Meth 1980 35 1 21 10.1016/0022-1759(80)90146-5
7. Coping with multiple virulence factors: which is most important? EE McClelland P Bernhardt A Casadevall, PLoS Pathog 2005 1 e40 16738705 10.1371/journal.ppat.0010040
8. Estimating the relative contributions of virulence factors for pathogenic microbes. EE McClelland P Bernhardt A Casadevall, Infect Immun 2006 74 1500 1504 16495520 10.1128/IAI.74.3.1500-1504.2006
9. Epitope location in the Cryptococcus neoformans capsule is a determinant of antibody efficacy. G Nussbaum W Cleare A Casadevall MD Scharff P Valadon, J Exp Med 1997 185 685 697 9034147 10.1084/jem.185.4.685
10. Immunoglobulin G3 blocking antibodies to Cryptococcus neoformans. G Nussbaum R Yuan A Casadevall MD Scharff, J Exp Med 1996 183 1905 1909 8666947 10.1084/jem.183.4.1905
11. Cutting edge: paradigm revisited: antibody provides resistance to Listeria infection. BT Edelson P Cossart ER Unanue, J Immunol 1999 163 4087 4090 10510340
12. Intracellular antibody neutralizes Listeria growth. BT Edelson ER Unanue, Immunity 2001 14 503 512 10.1016/S1074-7613(01)00139-X 11371353
13. Protection against pneumococcal pneumonia in mice by monoclonal antibodies to pneumolysin. MM Garcia-Suarez MD Cima-Cabal N Florez P Garcia R Cernuda-Cernuda A Astudillo F Vazquez lT De Jr FJ Mendez, Infect Immun 2004 72 4534 4540 15271913 10.1128/IAI.72.8.4534-4540.2004
14. Human monoclonal antibodies directed against toxins A and B prevent Clostridium difficile- induced mortality in hamsters. GJ Babcock TJ Broering HJ Hernandez RB Mandell K Donahue N Boatright AM Stack I Lowy R Graziano D Molrine DM Ambrosino WD Thomas Jr, Infect Immun 2006 74 6339 6347 16966409 10.1128/IAI.00982-06
15. Fine and domain-level epitope mapping of botulinum neurotoxin type A neutralizing antibodies by yeast surface display. R Levy CM Forsyth SL LaPorte IN Geren LA Smith JD Marks, J Mol Biol 2007 365 196 210 17059824 10.1016/j.jmb.2006.09.084